Through Reducing ROS Production, IL-10 Suppresses Caspase-1-Dependent IL-1β Maturation, thereby Preventing Chronic Neuroinflammation and Neurodegeneration
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Through Reducing ROS Production, IL-10 Suppresses Caspase-1-Dependent IL-1β Maturation, thereby Preventing Chronic Neuroinflammation and Neurodegeneration
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 2, Pages 465
Publisher
MDPI AG
Online
2020-01-13
DOI
10.3390/ijms21020465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration
- (2019) Dezhen Tu et al. Journal of Neuroinflammation
- MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration
- (2018) Eunju Lee et al. CELL DEATH AND DIFFERENTIATION
- Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis
- (2018) Brienne A. McKenzie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
- (2018) Richard Gordon et al. Science Translational Medicine
- The Interleukin-10 Family of Cytokines and Their Role in the CNS
- (2018) Amanda R. Burmeister et al. Frontiers in Cellular Neuroscience
- Glial contributions to neurodegeneration in tauopathies
- (2017) Cheryl E. G. Leyns et al. Molecular Neurodegeneration
- The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats
- (2017) Zhijuan Mao et al. NEUROCHEMICAL RESEARCH
- Inflammasome-dependent IL-1β release depends upon membrane permeabilisation
- (2016) F Martín-Sánchez et al. CELL DEATH AND DIFFERENTIATION
- Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency
- (2016) Dror S. Shouval et al. GASTROENTEROLOGY
- Balancing the immune response in the brain: IL-10 and its regulation
- (2016) Diogo Lobo-Silva et al. Journal of Neuroinflammation
- Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson’s Disease
- (2016) Chen Qiao et al. MOLECULAR NEUROBIOLOGY
- MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
- (2016) Yan Zhou et al. Molecular Neurodegeneration
- How neuroinflammation contributes to neurodegeneration
- (2016) R. M. Ransohoff SCIENCE
- Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
- (2015) Yiqing Yan et al. CELL
- Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy
- (2015) Ankit Saxena et al. CYTOKINE
- The therapeutic potential of interleukin-10 in neuroimmune diseases
- (2015) A.J. Kwilasz et al. NEUROPHARMACOLOGY
- Inflammasome activation has an important role in the development of spontaneous colitis
- (2014) J Zhang et al. Mucosal Immunology
- Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction
- (2014) Claire J Greenhill et al. ARTHRITIS RESEARCH & THERAPY
- Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies
- (2013) Gaia Codolo et al. PLoS One
- Cutting Edge: IL-10-Mediated Tristetraprolin Induction Is Part of a Feedback Loop That Controls Macrophage STAT3 Activation and Cytokine Production
- (2012) A. Gaba et al. JOURNAL OF IMMUNOLOGY
- NADPH oxidases: novel therapeutic targets for neurodegenerative diseases
- (2012) Hui-Ming Gao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Understanding the mechanism of IL-1β secretion
- (2011) Gloria Lopez-Castejon et al. CYTOKINE & GROWTH FACTOR REVIEWS
- HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration
- (2011) H.-M. Gao et al. JOURNAL OF NEUROSCIENCE
- Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid
- (2011) Samia Ragheb et al. Multiple Sclerosis Journal
- Inflammasome activation and IL-1β and IL-18 processing during infection
- (2011) Frank L. van de Veerdonk et al. TRENDS IN IMMUNOLOGY
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- -Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1
- (2010) E.-J. Lee et al. JOURNAL OF IMMUNOLOGY
- Unconventional secretion of tubby and tubby-like protein 1
- (2009) Nora B. Caberoy et al. FEBS LETTERS
- Tristetraprolin Is Required for Full Anti-Inflammatory Response of Murine Macrophages to IL-10
- (2009) B. Schaljo et al. JOURNAL OF IMMUNOLOGY
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Differential requirement for the activation of the inflammasome for processing and release of IL-1 in monocytes and macrophages
- (2008) M. G. Netea et al. BLOOD
- Strategies for use of IL-10 or its antagonists in human disease
- (2008) Anne O'Garra et al. IMMUNOLOGICAL REVIEWS
- Neuroinflammation and Oxidation/Nitration of -Synuclein Linked to Dopaminergic Neurodegeneration
- (2008) H.-M. Gao et al. JOURNAL OF NEUROSCIENCE
- The Nalp3 inflammasome is essential for the development of silicosis
- (2008) Suzanne L. Cassel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
- (2008) C. Dostert et al. SCIENCE
- Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
- (2008) Hui-Ming Gao et al. TRENDS IN IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More